Items where authors include "Mayer, J"
Up a levelArticle
Klionsky, DJ, Abdel-Aziz, AK, Abdelfatah, S et al. (2926 more authors) (2021) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17 (1). pp. 1-382. ISSN 1554-8627
Tausch, E, Beck, P, Schlenk, RF et al. (18 more authors) (2020) Prognostic or predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1. Haematologica: the hematology journal, 105 (10). pp. 2440-2447. ISSN 0390-6078
Offner, F, Robak, T, Janssens, A et al. (12 more authors) (2020) A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial. British Journal of Haematology, 190 (5). pp. 736-740. ISSN 0007-1048
Ovtchinnikov, E, Brown, R, Kolbitsch, C et al. (17 more authors) (2020) SIRF: Synergistic Image Reconstruction Framework. Computer Physics Communications, 249. 107087. ISSN 0010-4655
Winston, DJ, Mullane, KM, Cornely, OA et al. (157 more authors) (2018) Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. The Lancet, 391 (10135). pp. 2116-2127. ISSN 0140-6736
Burger, JA, Tedeschi, A, Barr, PM et al. (31 more authors) (2015) Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. New England Journal of Medicine, 373 (25). pp. 2425-2437. ISSN 0028-4793
Conference or Workshop Item
Hayden, PJ, Eikema, D-J, Koster, L et al. (21 more authors) (2020) O123: 25 Years of Autologous Transplantation for Myeloma in Ebmt Centres - Changing Practice Patterns. In: The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation, 29 Aug - 01 Sep 2020, Online.
Proceedings Paper
Burger, J, Tedeschi, A, Barr, PM et al. (32 more authors) (2016) International, randomized phase 3 study results: Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM)). In: Oncology Research and Treatment. Annual conference of the German, Austrian and Swiss Societies for Haematology and Medical Oncology, 14-18 Oct 2016, Leipzig, Germany. Karger Publishers , p. 6.